Recent BWV News
- Blue Water Vaccines Appoints Seasoned Commercial Operations Leader Frank Jaeger as Senior Vice President of Marketing and Business Development • GlobeNewswire Inc. • 02/06/2023 03:15:00 PM
- Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates • GlobeNewswire Inc. • 02/01/2023 02:15:00 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 01/31/2023 09:04:22 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/17/2023 01:36:38 PM
- Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors • GlobeNewswire Inc. • 01/17/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 01:51:07 PM
- Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco • GlobeNewswire Inc. • 01/09/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/06/2023 10:03:27 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 01/04/2023 12:14:06 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 01:41:31 PM
- Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives “Buy” Rating From Both • GlobeNewswire Inc. • 12/12/2022 01:30:00 PM
- Blue Water Vaccines, Inc. (BWV) Gets a Buy from H.C. Wainwright • TipRanks • 12/09/2022 11:25:11 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/06/2022 06:13:24 PM
- Blue Water Vaccines Organizes Key Opinion Leader Event to Discuss Unmet Need for Acute Otitis Media and Pneumonia Vaccine and Its Streptococcus pneumoniae Vaccine Candidate • GlobeNewswire Inc. • 12/06/2022 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/01/2022 01:37:06 PM
- Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress • GlobeNewswire Inc. • 12/01/2022 01:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/21/2022 04:34:57 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/21/2022 02:32:53 PM
- Blue Water Vaccines Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate Development from The University of Texas Health San Antonio • GlobeNewswire Inc. • 11/21/2022 01:00:00 PM
- Securities Registration: Employee Benefit Plan (s-8) • Edgar (US Regulatory) • 11/14/2022 10:48:23 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 10:36:17 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:55:28 PM
- Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program • GlobeNewswire Inc. • 11/10/2022 01:47:52 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/09/2022 09:06:27 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/08/2022 02:30:22 PM
FEATURED American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility PHOENIX, AZ (January 7, • Feb 7, 2023 9:17 AM
FEATURED Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone • Feb 7, 2023 7:00 AM
Chairman & CEO Joshua Sodaitis Announces Annual Letter to Shareholders • PTOP • Feb 7, 2023 10:00 AM
American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow • ERBB • Feb 7, 2023 9:17 AM
Good Gaming Inc. To Launch Its First Extreme Game Mob Wars For Advanced Players As Minecraft and Roblox Continue To Experience Rapid Growth • GMER • Feb 7, 2023 8:30 AM
B2Digital's B2 Fighting Series Kicks Off 2023 with New Single-Event Company Record at B2FS 178 • BTDG • Feb 7, 2023 8:30 AM